These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12445763)

  • 41. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community acquired pneumonia in children.
    Haq IJ; Battersby AC; Eastham K; McKean M
    BMJ; 2017 Mar; 356():j686. PubMed ID: 28255071
    [No Abstract]   [Full Text] [Related]  

  • 43. Review of treatment guidelines for community-acquired pneumonia.
    Niederman MS
    Am J Med; 2004 Aug; 117 Suppl 3A():51S-57S. PubMed ID: 15360097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic therapy for inpatients with community-acquired pneumonia in a developing country.
    Trinh HT; Hoang PH; Cardona-Morrell M; Nguyen HT; Vu DH; Dong PT; Cao TT; Nguyen ST; Pham VT; Moss L; Dinh K; Dartnell J; Nguyen HT
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):129-36. PubMed ID: 24648269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluoroquinolones for respiratory infections: too valuable to overuse.
    Williams JH
    Chest; 2001 Dec; 120(6):1771-5. PubMed ID: 11742900
    [No Abstract]   [Full Text] [Related]  

  • 46. Modulating treatment according to resistance patterns and local epidemiology.
    J Assoc Physicians India; 2013 Jul; 61(7 Suppl):32-7. PubMed ID: 24779156
    [No Abstract]   [Full Text] [Related]  

  • 47. Community-acquired pneumonia.
    Lynch JP; Martinez FJ
    Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Community-acquired pneumonia in children aged 2 months to 5 years: application of the WHO guidelines in a developed country setting (Switzerland).
    Dirlewanger M; Krahenbuhl JD; Fanconi S; Vaudaux B; Gehri M
    Eur J Pediatr; 2002 Aug; 161(8):460-1. PubMed ID: 12269258
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicenter, multinational observational studies: a new approach to studying community-acquired pneumonia.
    Ramirez J
    Respir Care Clin N Am; 2005 Mar; 11(1):35-44. PubMed ID: 15763220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoroquinolones for respiratory infection: too valuable to overuse (and too valuable to misuse!).
    Weiss K; Tillotson GS
    Chest; 2002 Sep; 122(3):1102-3; author reply 1103. PubMed ID: 12226065
    [No Abstract]   [Full Text] [Related]  

  • 52. New trends in the prevention and management of community-acquired pneumonia.
    Postma DF; van Werkhoven CH; Huijts SM; Bolkenbaas M; Oosterheert JJ; Bonten MJ
    Neth J Med; 2012 Oct; 70(8):337-48. PubMed ID: 23065981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guidelines for community-acquired pneumonia in the US and Canada: a practical approach to antibiotic selection.
    Ramirez JA
    Compr Ther; 2002; 28(3):201-7. PubMed ID: 12360632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lower respiratory tract infection and pneumonia in the community.
    Macfarlane J
    Semin Respir Infect; 1999 Jun; 14(2):151-62. PubMed ID: 10391409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-acquired pneumonia in northern Australia: low mortality in a tropical region using locally-developed treatment guidelines.
    Elliott JH; Anstey NM; Jacups SP; Fisher DA; Currie BJ
    Int J Infect Dis; 2005 Jan; 9(1):15-20. PubMed ID: 15603991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016].
    Ewig S; Höffken G; Kern WV; Rohde G; Flick H; Krause R; Ott S; Bauer T; Dalhoff K; Gatermann S; Kolditz M; Krüger S; Lorenz J; Pletz M; de Roux A; Schaaf B; Schaberg T; Schütte H; Welte T
    Pneumologie; 2016 Mar; 70(3):151-200. PubMed ID: 26926396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
    Moran G
    J Emerg Med; 2006 May; 30(4):377-87. PubMed ID: 16740445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
    Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
    Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community-acquired Acinetobacter baumannii pneumonia.
    Bachoumas K; Lebert C; Lacherade JC; Reignier J
    Med Mal Infect; 2015 Aug; 45(8):337-9. PubMed ID: 26141128
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical characteristics and outcomes of community-acquired pneumonia in western Saudi Arabia: A four-year retrospective analysis of medical records.
    Farahat FM; Bukhari OK; Basfar IA; Alammari AM; Zaatari AZ; Alsaedi AA; Alshamrani MM
    J Infect Public Health; 2021 Jul; 14(7):960-966. PubMed ID: 34130120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.